Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ahn

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Oncologist|February 25, 2021
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal CancerIbrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, et al.
Pancreas|June 4, 2026
Germline Cancer Testing in Unselected Patients With Neuroendocrine Neoplasms: A Multi-center Prospective StudyOluseyi Abidoye, Michael Golafshar, Katie Kunz, et al.
JCO Precision Oncology|April 3, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal CancerDaniel Walden, Felipe Batalini, Cody Eslinger, et al.
Nature Medicine|August 11, 2015
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinomaNemanja Rodić, Jared P Steranka, Alvin Makohon-Moore, et al.
Cancer|November 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 studyCody Eslinger, Daniel Walden, Alexandra Krivonos, et al.
JCO Precision Oncology|November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo ClinicOudai Sahwan, Fares Jamal, Rish Pai, et al.
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 2025
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and RecurrenceReetesh K Pai, Cody Eslinger, Kenneth Lee, et al.
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Oncologist|February 25, 2021
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal CancerIbrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, et al.
Pancreas|June 4, 2026
Germline Cancer Testing in Unselected Patients With Neuroendocrine Neoplasms: A Multi-center Prospective StudyOluseyi Abidoye, Michael Golafshar, Katie Kunz, et al.
JCO Precision Oncology|April 3, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal CancerDaniel Walden, Felipe Batalini, Cody Eslinger, et al.
Nature Medicine|August 11, 2015
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinomaNemanja Rodić, Jared P Steranka, Alvin Makohon-Moore, et al.
Cancer|November 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 studyCody Eslinger, Daniel Walden, Alexandra Krivonos, et al.
JCO Precision Oncology|November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo ClinicOudai Sahwan, Fares Jamal, Rish Pai, et al.
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 2025
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and RecurrenceReetesh K Pai, Cody Eslinger, Kenneth Lee, et al.
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
Pageof 6